Life sciences equity research: where the financial and technical converge

Brinson Patrick established equity research services in early 2012 to take advantage of the firm’s deep expertise in life sciences, and to deepen our ability to best serve the needs of Brinson Patrick’s valued clients.

Our research analysts have the life sciences industry experience that enables them to understand complex issues and emerging trends, and provide insights that others might miss. With thorough independent research, our analysts can uncover subtle and often over-looked details that may reveal potentially attractive investment opportunities.

The research team is committed to identifying and leveraging emerging sector trends and deriving the bottom-up, fundamental issues that can translate into materially different valuations. Experienced, diligent and focused, clients can rely on the fundamental research, veracity and insights we bring to the table.